Page last updated: 2024-08-21

dihydroergotamine and Nausea

dihydroergotamine has been researched along with Nausea in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.88)18.7374
1990's9 (52.94)18.2507
2000's3 (17.65)29.6817
2010's4 (23.53)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braillon, A1
Goadsby, PJ; Robbins, NM1
Chou, DE; Goadsby, PJ; Tso, AR1
Goadsby, PJ; Ito, H; Robbins, NM; Scheinman, MM1
Lake, AE; Saper, JR; Swidan, SZ1
Dalessio, D; Mathew, N; Sadowsky, C; Sheftell, F; Silberstein, SD; Solomon, S; Turkewitz, LJ; Winner, P1
Baskin, SM; Queiroz, LP; Rapoport, AM; Sheftell, FD; Siegel, SE; Weeks, RE1
Gallagher, RM1
Mathew, NT1
Lipton, RB1
Ford, KT; Ford, RG1
Barton, CW; Carleton, SC; Chelly, JE; Chudnofsky, CR; Johnson, G; Morris, DL; Pietrzak, MP; Rhee, KJ; Rosenberg, J; Shesser, RF; Starkman, S; Van Valen, MK1
Hopkins, MM; Schulman, EA; Silberstein, SD1
Backonja, M; Beinlich, B; Dulli, D; Schutta, HS1

Reviews

3 review(s) available for dihydroergotamine and Nausea

ArticleYear
MT 300--POZEN: dihydroergotamine mesylate injection.
    Drugs in R&D, 2003, Volume: 4, Issue:6

    Topics: Dihydroergotamine; Humans; Migraine Disorders; Nausea; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists

2003
Dosing and administration of ergotamine tartrate and dihydroergotamine.
    Headache, 1997, Volume: 37 Suppl 1

    Topics: Analgesics, Non-Narcotic; Cluster Headache; Dihydroergotamine; Dosage Forms; Ergotamine; Humans; Migraine Disorders; Nausea; Suppositories; Tablets; Vomiting

1997
Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.
    Headache, 1997, Volume: 37 Suppl 1

    Topics: Administration, Intranasal; Analgesics, Non-Narcotic; Animals; Consumer Product Safety; Dihydroergotamine; Drug Monitoring; Ergotamine; Humans; Migraine Disorders; Nausea; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic

1997

Trials

5 trial(s) available for dihydroergotamine and Nausea

ArticleYear
MT 300. Dihydroergotamine mesylate injection - POZEN.
    Drugs in R&D, 2003, Volume: 4, Issue:2

    Topics: Dihydroergotamine; Humans; Injections; Migraine Disorders; Nausea; Time Factors

2003
Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Dihydroergotamine Nasal Spray Multicenter Investigators.
    Headache, 1995, Volume: 35, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Dihydroergotamine; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Time Factors

1995
Concomitant administration of antiemetics is not necessary with intramuscular dihydroergotamine.
    The American journal of emergency medicine, 1994, Volume: 12, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Antiemetics; Child; Dihydroergotamine; Drug Therapy, Combination; Female; Humans; Incidence; Injections, Intramuscular; Male; Migraine Disorders; Nausea; Office Visits; Prospective Studies; Time Factors

1994
Acute treatment of migraine with dihydroergotamine nasal spray. Dihydroergotamine Working Group.
    Archives of neurology, 1996, Volume: 53, Issue:12

    Topics: Acute Disease; Administration, Intranasal; Adolescent; Adult; Aged; Dihydroergotamine; Double-Blind Method; Female; Hallucinations; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Placebos; Self Administration

1996
Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache.
    Annals of emergency medicine, 1998, Volume: 32, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Antiemetics; Dihydroergotamine; Double-Blind Method; Drug Combinations; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Hydroxyzine; Injections, Intramuscular; Male; Meperidine; Middle Aged; Migraine Disorders; Nausea; Pain Measurement; Prospective Studies; Time Factors

1998

Other Studies

9 other study(ies) available for dihydroergotamine and Nausea

ArticleYear
Letter re: Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache.
    Neurology, 2017, 05-30, Volume: 88, Issue:22

    Topics: Dihydroergotamine; Domperidone; Headache; Humans; Nausea

2017
Author response: Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache.
    Neurology, 2017, 05-30, Volume: 88, Issue:22

    Topics: Dihydroergotamine; Domperidone; Headache; Humans; Nausea

2017
Aprepitant for the management of nausea with inpatient IV dihydroergotamine.
    Neurology, 2016, Oct-11, Volume: 87, Issue:15

    Topics: Administration, Intravenous; Administration, Oral; Analgesics, Non-Narcotic; Antiemetics; Aprepitant; Dihydroergotamine; Humans; Inpatients; Migraine Disorders; Morpholines; Nausea; Prospective Studies; Retrospective Studies; Treatment Outcome

2016
Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache.
    Neurology, 2016, Dec-13, Volume: 87, Issue:24

    Topics: Adolescent; Adult; Aged; Antiemetics; Dihydroergotamine; Domperidone; Female; Headache; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Prospective Studies; Retrospective Studies; Young Adult

2016
Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache.
    Current pain and headache reports, 2005, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Antiemetics; Dihydroergotamine; Diphenhydramine; Drug Therapy, Combination; Female; Histamine H1 Antagonists; Humans; Injections, Intravenous; Male; Metoclopramide; Middle Aged; Migraine Disorders; Nausea

2005
Early and transient side effects of repetitive intravenous dihydroergotamine.
    Headache, 1996, Volume: 36, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Chronic Disease; Dihydroergotamine; Female; Headache; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Prospective Studies

1996
Continuous intravenous dihydroergotamine in the treatment of intractable headache.
    Headache, 1997, Volume: 37, Issue:3

    Topics: Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Dihydroergotamine; Drug Stability; Female; Headache; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Pain, Intractable

1997
Repetitive intravenous DHE in the treatment of refractory headache.
    Headache, 1990, Volume: 30, Issue:6

    Topics: Chronic Disease; Cluster Headache; Dihydroergotamine; Headache; Humans; Injections, Intravenous; Nausea; Retrospective Studies

1990
Haloperidol and lorazepam for the treatment of nausea and vomiting associated with the treatment of intractable migraine headaches.
    Archives of neurology, 1989, Volume: 46, Issue:7

    Topics: Adult; Dihydroergotamine; Female; Haloperidol; Humans; Lorazepam; Migraine Disorders; Nausea; Vomiting

1989